Value of pharmaceutical gross-to-net reduction in the U.S. 2012-2019

Published by
Matej Mikulic,
Feb 15, 2022
This statistic shows the total value of pharmaceutical manufacturers gross-to-net reductions on medications in the United States from 2012 to 2019, in billion U.S. dollars. In 2019, rebates and discounts provided by manufacturers totaled some 175 billion dollars.

Total value of pharmaceutical gross-to-net reductions in the U.S. from 2012 to 2019 (in billion U.S. dollars)

Loading statistic...

Details: United States; Drug Channels Institute

© Statista 2024
Download

Statistics on " Pharmaceutical market in Thailand "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market in Thailand

Overview

6

Sales and production

5

Industry performance

5

Pharmaceutical licenses

5

International trade

7

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

SanofiGlobal pharmaceutical industryTop pharmaceutical drugsPfizerNovartis

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu
User